1984
DOI: 10.1016/0300-483x(84)90122-7
|View full text |Cite
|
Sign up to set email alerts
|

Subchronic toxicity of all-trans-retinoic acid and retinylidene dimedone in Sprague-Dawley rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
13
0

Year Published

1985
1985
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 6 publications
4
13
0
Order By: Relevance
“…The phenotype observed in the Cyp26a1 -/-b1 -/mice is very similar to the observed phenotype in mice and rats after chronic dosing with atRA. While acute atRA toxicity results in hair loss, dermal and mucosal alterations and loss of body weight (Kretzschmar and Leuschner, 1975;Biesalski, 1989), chronic atRA treatment has been shown to cause lymphoid hyperplasia, extramedullary hematopoiesis and hyperkeratosis (Kurtz et al, 1984), findings that are very similar to the phenotype observed in this study. The observations that exogenous atRA clearance was reduced in the Cyp26a1 -/-b1 -/mice by 80% and the Cyp26a1 -/-b1 -/mice were hypersensitive to atRA toxicity, further confirm the critical role of Cyp26a1 and Cyp26b1 in clearing atRA in post-natal animals.…”
Section: -Cis-rasupporting
confidence: 79%
See 1 more Smart Citation
“…The phenotype observed in the Cyp26a1 -/-b1 -/mice is very similar to the observed phenotype in mice and rats after chronic dosing with atRA. While acute atRA toxicity results in hair loss, dermal and mucosal alterations and loss of body weight (Kretzschmar and Leuschner, 1975;Biesalski, 1989), chronic atRA treatment has been shown to cause lymphoid hyperplasia, extramedullary hematopoiesis and hyperkeratosis (Kurtz et al, 1984), findings that are very similar to the phenotype observed in this study. The observations that exogenous atRA clearance was reduced in the Cyp26a1 -/-b1 -/mice by 80% and the Cyp26a1 -/-b1 -/mice were hypersensitive to atRA toxicity, further confirm the critical role of Cyp26a1 and Cyp26b1 in clearing atRA in post-natal animals.…”
Section: -Cis-rasupporting
confidence: 79%
“…Hypervitaminosis A cases have changes in central nervous system, liver disorders, changes to the bone and effects on skin and mucous membranes, but the exact mechanisms and the retinoids causing these toxicities cannot be easily delineated (Biesalski, 1989). Chronic (13-week) dosing of atRA to rats (14 or 50 mg/kg) caused lymphoid hyperplasia, splenic extramedullary hematopoiesis, hyperkeratosis of the non-glandular stomach, long-bone fractures, hematological changes and testicular degeneration and atrophy (Kurtz et al, 1984). After acute treatment the toxic doses are much higher (Kretzschmar and Leuschner, 1975;Biesalski, 1989).…”
Section: Introductionmentioning
confidence: 99%
“…Rats that were administered 14 mg/kg of all-trans-RA for 13 weeks showed signs of growth arrest, anemia, elevated serum alkaline phosphatase, bone fracture and testicular degeneration. 48 Microcephaly in particular is a recognized malformation of the central nervous system associated with hypervitaminosis A in early pregnancy. 49 Benke 50 described two infants with microcephaly, frontal bossing, hydrocephalus, microphthalmia and small, malformed and low-set undifferentiated ears whose mothers had taken the drug isotretinoin in the first trimester of pregnancy.…”
Section: Similarities To Hypervitaminosis Amentioning
confidence: 99%
“…[Windhorst and Nigra 1982;Frankel et al, 1992Frankel et al, , 1994. Subchronic toxicity including alterations in body weight gain, bone resorption, RBC count, hemoglobin, hematocrit, cholesterol, serum albumin, and alkaline phosphatase in mice and rats have been described [Hixson and Denine 1978;Hixson et al, 1979;Teelman 1983;Kurtz et al, 1984]. The main toxicities observed in the present study were consistent with the previous reports mentioned above, and severe toxic effects were observed after continuous plasma exposure to atRA over 10 ng/ml for more than 1 week, and, therefore, it could be suggested that the minimum toxic concentration of atRA was around 10 ng/ml of plasma.…”
Section: Discussionmentioning
confidence: 99%